K. H. Kurth - Concepedia

Author

K. H. Kurth

University of Amsterdam

Also Known As

C. Bouffioux, K H Kurth, K Kurth, K-H Kurth, K. -H. Kurth, K. H. KURTH, K. H. Kurth, K. Kurth, K.-H. Kurth, K.H. KURTH

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Erasmus University Rotterdam European Organisation for Research and Treatment of Cancer Norwegian Cancer Society

About

K. H. Kurth is an author at University of Amsterdam specializing in urology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	329
2	Biomolecular Engineering	1	1	15
3	Cell Biology	1	1	18
4	Immunology	1	1	74
5	Pharmacology	1	1	13

K. H. Kurth

Publications

856

Citations

H-Index

Page 1

	Year	Citations
Original Articles: Bladder Cancer: Intravesical Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Results of 2 European Organization for Research and Treatment of Cancer Randomized Trials With Mitomycin C and Doxorubicin Comparing Early Versus Delayed Instillations and Short-Term Versus Long-Term Treatment Ch. Bouffioux, K. H. Kurth, A. Bono, The Journal of Urology	1995	175
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma : results of 2 european organization for research and treatment of cancer randomized trials with Mitomycin C and Doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment C Bouffioux, K. H. Kurth, A. Bono, Data Archiving and Networked Services (DANS)	1995	124
Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle‐related nuclear antigen (Ki‐67) A Mulder, J. C. S. P. Van Hootegem, Richard Sylvester, The Journal of Pathology	1992	105
Original Articles C Bouffioux, K. H. Kurth, Aldo Bono, The Journal of Urology Urological ResearchUrologySurgical OncologyGenitourinary CancerMedicine	1995	79
Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer Elizabeth C. de Boer, László Somogyi, G. J. W. De Ruiter, Urological Research UrologyCancer ImmunosurveillanceGenitourinary CancerSuperficial Bladder CancerIntravesical Bcg Therapy	1997	74
Prognostic factors in superficial bladder tumors K. H. Kurth, L. Denis, Fiebo ten Kate, Ghent University Academic Bibliography (Ghent University) Prognostic FactorsUrologySurgical OncologyGenitourinary CancerMedicine	1992	52
Mitomycin C Versus Estramustine in the Treatment of Hormone Resistant Metastatic Prostate Cancer: Thefinal Analysis of the European Organization Forresearch and Treatment of Cancer, Genitourinarygroup Prospective Randomized Phase III Study (30865) Don Newling, S.D. Fosså, U. W. Tunn, The Journal of Urology	1993	30
Effects of isoniazid on the proliferation and cytokine production of bladder cancer cells <i>in vitro</i> induced by bacille Calmette‐Guérin Rob F. M. Bevers, Elizabeth C. de Boer, K. H. Kurth, British Journal of Urology	1997	27
Single-dose intravesical Epodyl after TUR of Ta TCC bladder carcinoma K. H. Kurth, P. A. Maksimovic, Wim C.J. Hop, World Journal of Urology UrologySurgical OncologyGenitourinary CancerMedicineSingle-dose Intravesical Epodyl	1983	25
Immunostimulation in the urinary bladder by local application ofNocardia rubra cell wall skeleton preparation (Rubratin) for superficial bladder cancer immunotherapy — a phase I/II study T.M. De Reijke, Elizabeth C. de Boer, D. H. J. Schamhart, Urological Research Urological ResearchUrologyGenitourinary CancerPhase I/ii StudyLocal Application	1997	21

Page 1